| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/03/2000 | EP0997152A1 Remedies for lymphocytic tumors |
| 05/03/2000 | EP0996857A2 Cancer associated nucleic acids and polypeptides |
| 05/03/2000 | EP0996733A1 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase from human |
| 05/03/2000 | EP0996730A1 Nucleic acid vaccines encoding g protein of respiratory syncytial virus |
| 05/03/2000 | EP0996728A2 IMPROVED ANTI-IgE ANTIBODIES AND METHOD OF IMPROVING POLYPEPTIDES |
| 05/03/2000 | EP0996727A1 Gene conferring obese phenotype |
| 05/03/2000 | EP0996725A1 Human nk-3 related prostate specific gene-1 |
| 05/03/2000 | EP0996724A1 Polynucleotides encoding a growth factor-like protein (as amended) |
| 05/03/2000 | EP0996723A1 Human phosphatidylinositol transfer protein gamma |
| 05/03/2000 | EP0996722A2 Secreted proteins and polynucleotides encoding them |
| 05/03/2000 | EP0996721A2 Secreted proteins and polynucleotides encoding them |
| 05/03/2000 | EP0996716A1 Zggbp1,novel peptides related to bipolar affective disorder type 1, sequences and uses thereof |
| 05/03/2000 | EP0996713A1 Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin |
| 05/03/2000 | EP0996638A2 Methods and compositions for treating abnormal cell growth related to unwanted guanine nucleotide exchange factor activity |
| 05/03/2000 | EP0996637A1 Recombinant protein c and protein s variants |
| 05/03/2000 | EP0996630A2 Irs-p53h, human insulin receptor tyrosine kinase substrate |
| 05/03/2000 | EP0996629A2 Disulfide crosslinked glycoprotein hormone analogs, their preparation and use |
| 05/03/2000 | EP0996628A2 Mammalian neuro-growth factor like protein |
| 05/03/2000 | EP0996626A1 Glycine transporter |
| 05/03/2000 | EP0996467A1 Txu-7-pap immunotoxin and use thereof |
| 05/03/2000 | EP0996463A2 Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions |
| 05/03/2000 | EP0996460A1 TREATMENT OF ACUTE LUNG INJURY AND FIBROSIS WITH ANTAGONISTS OF $g(a)v$g(b)6 |
| 05/03/2000 | EP0687302B1 Bi-functional expression system |
| 05/03/2000 | EP0624100B1 Dna encoding a human serotonin receptor (5-ht 4b) and uses thereof |
| 05/03/2000 | EP0612350B1 Ubiquitin-specific proteases |
| 05/03/2000 | EP0560947B1 Trivalent monospecific antigen binding proteins |
| 05/03/2000 | EP0514481B1 Merosin, nucleic acids encoding, fragments and uses thereof |
| 05/03/2000 | EP0460042B1 Vector for integration site independent gene expression in mammalian host cells |
| 05/03/2000 | CN1251861A Human T cell activating protein gene and its coded polypeptide, preparing process and application |
| 05/03/2000 | CN1251860A Human gene sequence and its coded polypeptide, preparing process and application |
| 05/03/2000 | CN1251840A Constitutive fusion protein of ridamycin as anticancer antibiotic and single-chain antibody |
| 05/03/2000 | CN1251839A Activating agent for methanol dehydrogenase and genes thereof |
| 05/03/2000 | CN1251772A Process for extracting granulocyte stimulating factor and its compound polyose capsules |
| 05/02/2000 | US6057435 Nucleic acid coding for polypeptide which binds to receptor tyrosine kinase containing immunoglobulin-like and epidermal growth factor homology domains expressed in vascular endothelial cells; diagnosis/imaging; angiogenesis inhibition |
| 05/02/2000 | US6057432 CysS |
| 05/02/2000 | US6057426 Nucleotide and amino acid sequences of polypeptide capable of inducing leukocyte migration and/or activating leukocytes in a dose-dependent manner; diagnosis/screening/therapy; for increasing cell layer permeability for drug circulation |
| 05/02/2000 | US6057424 Method and apparatus to synthesize DNA and DNA-like molecular structures by applying electric fields to gaseous mixtures of chemical reactants containing template particulate matter |
| 05/02/2000 | US6057292 Method for inhibiting growth hormone action |
| 05/02/2000 | US6057287 Kallikrein-binding "Kunitz domain" proteins and analogues thereof |
| 05/02/2000 | US6057155 Nucleic acid encoding a chimeric adenovirus fiber protein constrained by a non-preexisting loop; for efficient, direct entry of the nucleic acid-containing vector into cells for targeted gene therapy |
| 05/02/2000 | US6057152 Recombinant viral vector system |
| 05/02/2000 | US6057143 Recombinant enzymatically active calpain expressed in a baculovirus system |
| 05/02/2000 | US6057142 Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
| 05/02/2000 | US6057133 Fusion protein associated with cell growth and regulation; for the activation of bone marrow propagation; for treatment of cancer, asthma and inflammation |
| 05/02/2000 | US6057132 Nucleotide sequences encoding apoptosis associated Bbk protein |
| 05/02/2000 | US6057131 Preparation and use of sialylated glycoforms of soluble complement receptor 1 (CR1) |
| 05/02/2000 | US6057128 MU-1, member of the cytokine receptor family |
| 05/02/2000 | US6057124 Nucleic acids encoding ligands for HEK4 receptors |
| 05/02/2000 | US6057123 Stem cell inhibiting proteins |
| 05/02/2000 | US6057122 Antiangiogenic peptides polynucleotides encoding same and methods for inhibiting angiogenesis |
| 05/02/2000 | US6057121 Method of catalyzing stereochemical reactions |
| 05/02/2000 | US6057115 Process for producing GM2 specific antibodies |
| 05/02/2000 | US6057108 Human ARF-related proteins |
| 05/02/2000 | US6057104 Disruption of the mammalian Rad51 protein and disruption of proteins that associate with mammalian Rad51 for hindering cell proliferation |
| 05/02/2000 | US6057101 Identification and comparison of protein-protein interactions that occur in populations and identification of inhibitors of these interactors |
| 05/02/2000 | US6057098 Preparing genetically engineered phage envelope protein; providing phage packages coding varying number of envelope protein, contacting the library with a receptor, separating phage packages |
| 05/02/2000 | US6056959 CD40 antigen antibody complex |
| 05/02/2000 | CA2105057C Dna sequences which code for virulence characteristics of streptococcus suis and part thereof polypeptides and antibodies derived therefrom and the use thereof for the diagnosis of and protection against infection by s. suis in mammals, including man |
| 05/02/2000 | CA2104014C Structural gene of pneumococcal protein |
| 05/02/2000 | CA2017636C Derivative of tissue-type plasminogen activator |
| 05/02/2000 | CA2012170C Novel method of ovulation induction in humans |
| 05/02/2000 | CA2011878C Immunogenic regions on the e7 protein of human papillomavirus type 16 |
| 05/02/2000 | CA1340982C Protamine-reactive igm antibodies |
| 05/02/2000 | CA1340978C Purification, cloning and characterization of the gene for interleukin 1 |
| 04/27/2000 | WO2000023955A1 Virus-like particles for the induction of autoantibodies |
| 04/27/2000 | WO2000023602A2 Regulated expression using conditional er retention domains |
| 04/27/2000 | WO2000023601A1 Delivery system for porcine somatotropin |
| 04/27/2000 | WO2000023594A1 BIOACTIVE PEPTIDES AND PEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHrP) |
| 04/27/2000 | WO2000023588A2 G-protein coupled receptors |
| 04/27/2000 | WO2000023579A1 Functionally assembled antigen-specific intact recombinant antibody and a method for production thereof |
| 04/27/2000 | WO2000023572A1 Tnfr related gene 12 |
| 04/27/2000 | WO2000023565A2 Novel neuropilin/growth factor binding and uses thereof |
| 04/27/2000 | WO2000023473A1 Multiple domain glycoprotein hormones and methods of using |
| 04/27/2000 | WO2000023472A2 Interferon-beta fusion proteins and uses |
| 04/27/2000 | WO2000023468A1 HUMAN PROTEINS STAM2a AND STAM2b AND cDNAS ENCODING THESE MOLECULES |
| 04/27/2000 | WO2000023466A2 Human rna binding proteins |
| 04/27/2000 | WO2000023459A1 Inhibitors of platelet activation and recruitment |
| 04/27/2000 | WO2000023094A2 Methods of inhibiting platelet activation and recruitment |
| 04/27/2000 | WO2000023087A1 Polyspecific binding molecules and uses thereof |
| 04/27/2000 | WO2000023083A1 Neuroprotective truncated bax polypeptides |
| 04/27/2000 | WO2000022932A1 Utilization of an antifungal protein from streptomyces tendae against plant pathogenic fungi |
| 04/27/2000 | WO2000012559B1 Monoclonal antibodies against s100 |
| 04/27/2000 | WO2000006742A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 04/27/2000 | WO2000005265A3 Anti-crr2 antibodies and methods of use therefor |
| 04/27/2000 | WO1999067282A3 Olfactory receptors and their uses |
| 04/27/2000 | WO1999057271A9 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides |
| 04/27/2000 | WO1998056811A8 Plant grab proteins |
| 04/27/2000 | DE19849044A1 New polycythemia rubra vera-related polypeptide useful for diagnosis and for developing therapeutic antibodies |
| 04/27/2000 | DE19848517A1 Controlling phytopathogenic fungi, useful particularly against Botrytis cinerea resistant to known fungicides, by treatment with peptide from Streptomyces tendae |
| 04/27/2000 | CA2347706A1 Utilization of an antifungal protein from streptomyces tendae against plant pathogenic fungi |
| 04/27/2000 | CA2347654A1 Human rna binding proteins |
| 04/27/2000 | CA2347409A1 Human proteins stam2a and stam2b and cdnas encoding these molecules |
| 04/27/2000 | CA2347080A1 Tnfr related gene 12 |
| 04/27/2000 | CA2347062A1 Multiple domain glycoprotein hormones and methods of using |
| 04/27/2000 | CA2346799A1 Delivery system for porcine somatotropin |
| 04/27/2000 | CA2346798A1 Novel neuropilin/growth factor binding and uses thereof |
| 04/27/2000 | CA2345382A1 Inhibitors of platelet activation and recruitment |
| 04/27/2000 | CA2344605A1 G-protein coupled receptors |
| 04/27/2000 | CA2343094A1 Interferon-beta fusion proteins and uses |
| 04/26/2000 | EP0995798A1 Transcription factor of MHC class II genes, substances capable of inhibiting this new transcription factor and medical uses of these substances |